Predictors of interleukin-6 elevation in older adults.
OBJECTIVE
To investigate the characteristics of older adults who develop high interleukin-6 (IL-6) levels at 3-year follow-up.


METHODS
Population-based study of adults living in Tuscany, Italy.


METHODS
Community.


METHODS
Adults aged 65 and older and were selected for this study. Of 1,155 baseline participants aged 65 and older, 741 had IL-6 measurements at baseline and 3-year follow-up.


METHODS
The uppermost quartile of IL-6 was used as the threshold for defining high IL-6 (> or =4.18 pg/mL). Serum IL-6 levels were assessed using enzyme immunoassay.


RESULTS
Of the 581 participants with IL-6 levels less than 4.18 pg/mL at baseline, 106 (18.2%) had developed high IL-6 at follow-up. Although women had lower IL-6 levels at baseline than men, the risk of developing high IL-6 did not differ according to sex. High adiposity, defined as a body mass index of 30.0 kg/m(2) or higher (odds ratio (OR)=2.63, 95% confidence interval (CI)=1.40-4.96), and large waist circumference, defined as 102 cm or greater for men and 88 cm or greater for women (OR=2.05, 95% CI=1.24-3.40), were significant predictors of developing high IL-6 at follow-up. Other significant predictors were presence of three or more chronic diseases (OR=3.66, 95% CI=1.54-8.70), higher baseline IL-6 (OR=1.82, 95% CI=1.39-2.38) and higher white blood cell count (OR=1.24, 95% CI=1.06-1.45). Faster walking speed associated with decreased risk of progressing to elevated IL-6 (OR=0.83, 95% CI=0.74-0.92).


CONCLUSIONS
Older age, greater adiposity, slower walking speed, higher disease burden, and higher white blood cell count were associated with greater risk of IL-6 elevation over a 3-year period. Future research should target older adults with these characteristics to prevent progression to a proinflammatory state.
Zhu
Shuhan
S
School of Medicine, Case Western Reserve University, Cleveland, Ohio.
Patel
Kushang V
KV
Bandinelli
Stefania
S
Ferrucci
Luigi
L
Guralnik
Jack M
JM
D000367:Age Factors; D000375:Aging / Q000276:immunology*; D015992:Body Mass Index; D002908:Chronic Disease / Q000453:epidemiology; D015331:Cohort Studies; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D007558:Italy; D007958:Leukocyte Count; D008137:Longitudinal Studies; D008297:Male; D051346:Mobility Limitation; D012016:Reference Values; D012307:Risk Factors; D012737:Sex Factors; D013223:Statistics as Topic; D049629:Waist-Hip Ratio
D015850:Interleukin-6
Circulation. 2007 Sep 11;116(11):1234-41
17709633
J Am Geriatr Soc. 1993 Feb;41(2):176-81
8426042
Circulation. 2000 Dec 19;102(25):3060-7
11120695
Am J Med. 1999 May;106(5):506-12
10335721
Am J Clin Nutr. 2002 Apr;75(4):683-8
11916754
Blood. 2005 Mar 15;105(6):2294-9
15572589
Circulation. 2001 Feb 20;103(7):947-53
11181468
J Am Geriatr Soc. 1999 Jun;47(6):639-46
10366160
Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:3-10
16225463
Immunol Allergy Clin North Am. 2003 Feb;23(1):15-39
12645876
J Gerontol A Biol Sci Med Sci. 2006 Jun;61(6):575-84
16799139
Am J Cardiol. 2003 Sep 1;92(5):522-8
12943870
Biochem J. 1990 Feb 1;265(3):621-36
1689567
Circulation. 2003 Mar 25;107(11):1486-91
12654604
Circulation. 2003 Nov 11;108(19):2317-22
14568895
Nat Med. 2006 Sep;12(9):1005-15
16960575
Clin Diagn Lab Immunol. 2001 Mar;8(2):333-8
11238217
J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):242-8
15031308
Annu Rev Immunol. 1990;8:253-78
2188664
Am J Med. 2006 Jun;119(6):526.e9-17
16750969
J Am Geriatr Soc. 2007 Nov;55(11):1801-7
17727645
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
11234459